intrins
disord
protein
idp
found
wide
associ
human
diseas
may
serv
potenti
drug
design
target
howev
drug
design
target
idp
still
earli
stage
progress
drug
design
usual
achiev
use
experiment
screen
howev
structur
disord
idp
make
difficult
character
interact
ligand
use
experi
alon
better
understand
structur
idp
interact
small
molecul
ligand
perform
extens
simul
cmyc
peptid
bind
report
small
molecul
inhibitor
ligand
found
conform
space
apo
cmyc
peptid
rather
dispers
conform
peptid
stabil
mainli
charg
interact
hydrogen
bond
bind
ligand
cmyc
remain
disord
ligand
found
bind
cmyc
differ
site
along
chain
behav
like
ligand
cloud
contrast
ligand
bind
rigid
target
protein
usual
result
domin
bound
structur
ligand
bind
idp
may
better
describ
ligand
cloud
around
protein
cloud
nevertheless
bind
ligand
nonligand
cmyc
target
could
clearli
distinguish
present
studi
provid
insight
help
improv
ration
drug
design
target
idp
intrins
disord
protein
idp
discov
protein
lack
stabl
threedimension
nativ
structur
physiolog
condit
idp
sometim
describ
protein
cloud
structur
flexibl
dynam
conform
ensembl
variou
bioinformat
method
develop
predict
idp
base
sequenc
reveal
idp
abund
kingdom
life
exampl
protein
eukaryot
cell
possess
disord
region
longer
residu
flexibl
chain
result
advantag
proteinprotein
interact
idp
play
import
role
variou
critic
physiolog
process
regul
transcript
translat
cellular
signal
transmiss
protein
phosphoryl
molecular
assembl
hand
idp
also
advers
effect
reveal
mani
idp
associ
human
diseas
cancer
cardiovascular
diseas
amyloidosi
neurodegen
diseas
diabet
also
report
swissprot
keyword
eleven
sever
diseas
strongli
correl
idp
given
abund
biolog
import
idp
regard
promis
potenti
drug
target
compar
ration
drug
design
target
order
protein
drug
design
target
idp
still
infanc
though
gener
strategi
propos
studi
limit
system
name
cmycmax
among
oncoprotein
cmyc
encourag
exampl
cmyc
transcript
factor
basic
helixloophelix
leucin
zipper
bhlhzip
domain
becom
activ
form
dimer
partner
protein
max
unbound
form
cmyc
max
disord
howev
dimer
form
undergo
coupl
fold
bind
cancer
cell
cmyc
protein
express
persist
mutat
myc
gene
caus
unregul
express
cell
prolifer
signal
transmiss
therefor
inhibit
either
overexpress
cmyc
andor
dimer
max
may
provid
therapi
cancer
yin
et
al
use
highthroughput
experiment
screen
success
identifi
seven
compound
inhibit
dimer
cmyc
max
biophys
studi
use
nuclear
magnet
reson
nmr
circular
dichroism
cd
fluoresc
assay
verifi
three
differ
bind
site
residu
bhlhzip
domain
cmyc
bind
site
contain
sever
success
residu
independ
bind
differ
small
molecul
note
bind
small
molecul
inhibitor
cmyc
sequenc
remain
disord
make
detail
experiment
character
molecular
interact
almost
imposs
therefor
inhibit
mechan
still
unclear
exampl
recent
studi
use
drifttim
ion
mobil
mass
spectrometri
suggest
bind
cmyc
inhibitor
specif
previous
thought
lack
conform
data
also
hamper
applic
welldevelop
structurebas
drug
design
approach
optim
inhibit
molecular
simul
use
understand
characterist
idp
provid
atom
descript
molecular
interact
coarsegrain
model
allatom
simul
use
investig
idp
recent
knott
best
use
largescal
replica
exchang
molecular
dynam
remd
simul
wellparameter
forc
field
obtain
conform
ensembl
nuclear
coactiv
bind
domain
transcript
coactiv
cbp
simul
result
good
agreement
nmr
smallangl
xray
scatter
measur
valid
efficaci
allatom
simul
explor
highli
dynam
conform
idp
cmycinhibitor
complex
describ
michel
cuchillo
built
structur
ensembl
use
allatom
simul
cmyc
without
inhibitor
found
bound
multipl
distinct
bind
site
interact
cmyc
howev
cmyc
segment
use
simul
contain
residu
cover
bind
site
residu
unclear
inhibitor
would
interact
longer
segment
cmyc
specif
interact
would
present
studi
conduct
extens
allatom
molecular
dynam
md
simul
investig
cmyc
conform
ensembl
interact
smallmolecul
inhibitor
first
perform
implicitsolv
remd
simul
clarifi
conform
featur
unbound
cmyc
next
perform
md
simul
explicit
water
model
explor
detail
interact
cmyc
final
neg
control
use
differ
peptid
segment
cmyc
simul
address
issu
interact
specif
conform
ensembl
obtain
use
clarifi
structur
featur
cmyc
bind
mechan
inhibitor
also
provid
refer
structur
drug
design
target
cmyc
via
structurebas
approach
conform
sampl
idp
molecular
model
challeng
energi
landscap
idp
rel
flat
present
studi
extens
remd
simul
use
implicit
solvent
model
perform
explor
conform
characterist
cmyc
accumul
total
simul
time
reach
ms
see
method
cmyc
truncat
construct
fulllength
cmyc
conform
properti
cmyc
bound
state
dynam
unbound
state
studi
experiment
use
cd
nmr
spectroscopi
like
averag
conform
built
base
chemic
shift
data
meant
defin
detail
structur
featur
compar
simul
result
avail
experiment
result
assess
sampl
qualiti
remd
simul
comput
h
c
chemic
shift
simul
conform
ensembl
use
shift
compar
comput
valu
experi
valu
figur
agreement
reason
though
excel
deviat
averag
chemic
shift
valu
simul
ensembl
experiment
valu
observ
previous
sever
studi
idp
chemic
shift
calcul
perform
use
sever
softwar
shiftx
camshift
sparta
also
show
deviat
comput
experiment
valu
figur
possibl
reason
chemic
shift
difficult
calcul
accur
underli
parameter
appli
current
softwar
calcul
chemic
shift
optim
order
protein
idp
interestingli
backcalcul
chemic
shift
nmrrefin
structur
use
either
shift
shiftx
softwar
result
valu
also
deviat
experiment
one
figur
addit
ensembl
natur
idp
conform
suggest
chemic
shift
idp
describ
distribut
mere
averag
valu
calcul
distribut
h
chemic
shift
obtain
simul
summar
figur
h
chemic
shift
distribut
broad
rang
experiment
valu
indic
arrow
figur
locat
close
center
distribut
indic
valid
conform
sampl
data
h
n
c
c
b
chemic
shift
given
figur
show
similar
behavior
h
chemic
shift
also
comput
distribut
backbon
dihedr
angl
ramachandran
w
plot
simul
dihedr
angl
nmrrefin
apo
structur
lie
well
within
simul
distribut
figur
secondari
structur
content
simul
structur
also
calcul
compar
estim
experiment
chemic
shift
figur
helix
polyprolin
ii
content
simul
structur
consist
experiment
structur
figur
howev
sheet
content
simul
structur
much
lower
sheet
content
experiment
structur
previou
studi
shorter
cmyc
segment
cmyc
similar
underestim
sheet
content
observ
simul
structur
defici
sheet
content
simul
structur
might
caus
bia
forc
field
although
cmyc
intrins
disord
possess
high
content
residu
helic
structur
simul
helix
propens
figur
show
three
helic
region
separ
prolin
residu
intrins
disord
protein
idp
exist
conform
ensembl
chang
rapidli
import
common
class
protein
kingdom
life
idp
wide
associ
human
diseas
may
serv
potenti
drug
design
target
howev
drug
design
target
idp
difficult
limit
exampl
report
one
exampl
oncoprotein
cmyc
seven
inhibitor
discov
experiment
screen
understand
small
inhibitor
molecul
bind
cmyc
may
help
understand
bind
mechan
idp
ligand
present
studi
conduct
extens
molecular
dynam
simul
explor
bind
mechan
cmyc
peptid
inhibitor
found
could
bind
cmyc
differ
site
along
peptid
chain
bind
behavior
could
describ
ligand
cloud
even
bound
state
structur
cmyc
peptid
remain
dynam
ensembl
compar
cmyc
peptid
bind
cmyc
bind
select
specif
bind
high
interact
idp
ligand
perhap
describ
scenario
ligand
cloud
around
protein
cloud
clarifi
conform
featur
cmyc
backbonermsd
cluster
cutoff
conform
perform
repres
structur
central
structur
group
first
eight
group
depict
figur
somewhat
collaps
compar
fulli
extend
structur
possess
rich
residu
helic
structur
state
consider
popul
use
refer
ration
drug
design
target
cmyc
exist
residu
structur
may
relat
function
misfold
prevent
idp
unwant
interact
nonn
partner
quantit
analysi
distribut
dimens
helix
content
provid
figur
mean
radiu
gyrat
around
much
smaller
expect
valu
random
coil
chain
length
mean
helix
content
conform
ensembl
show
broad
distribut
result
indic
cmyc
disord
natur
interconvers
dispers
structur
occur
reveal
conform
apo
cmyc
stabil
analyz
lennardjon
electrostat
residueresidu
interact
among
residu
figur
lennardjon
interact
matrix
rather
weak
figur
indic
conform
disord
pack
collaps
structur
poor
find
consist
contact
map
show
residueresidu
contact
dispers
low
magnitud
figur
electrostat
interact
hand
compar
strong
figur
probabl
nearli
onethird
residu
cmyc
charg
residu
favor
electrostat
interact
residu
residu
figur
result
electrostat
attract
residu
opposit
charg
residu
like
also
contribut
electrostat
interact
form
hydrogen
bond
figur
therefor
chargepair
interact
hydrogen
bond
main
stabil
factor
cmyc
conform
conduct
md
simul
explicit
solvent
model
investig
interact
cmyc
inhibitor
inhibitor
among
seven
inhibitor
cmyc
bind
site
loop
region
bhlhzip
domain
cmyc
want
see
whether
stabl
local
structur
induc
interact
flexibl
loop
region
experiment
studi
mixtur
two
chiral
form
r
form
figur
simul
chiral
form
test
comparison
apo
cmyc
simul
explicit
solvent
model
accumul
simul
time
group
ms
see
method
calcul
compar
simul
chemic
shift
experiment
chemic
shift
implicit
solvent
remd
explicit
solvent
simul
figur
reason
agreement
found
exampl
averag
discrep
simul
experiment
chemic
shift
ha
atom
apo
md
simul
explicit
solvent
model
remd
simul
respect
see
tabl
rel
bind
free
energi
cmyc
two
chiral
form
analyz
md
trajectori
remd
simul
red
helix
sheet
content
comput
use
dssp
method
polyprolin
ii
content
comput
pross
softwar
experiment
data
black
secondari
structur
content
estim
chemic
shift
use
b
helix
propens
remd
simul
use
dssp
method
use
molecular
mechanicpoissonboltzmann
surfac
area
mmpbsa
method
result
analysi
togeth
averag
nonbond
interact
u
nonbond
lennardjon
electrostat
potenti
cmyc
given
tabl
found
interact
cmyc
form
much
stronger
interact
r
form
differ
u
nonbond
r
form
kcalmol
close
differ
dh
mmpbsa
kcalmol
differ
bind
free
energi
r
form
kcalmol
result
bindingaffin
ratio
r
form
therefor
compar
bind
form
cmyc
bind
r
form
ignor
thu
holo
system
form
discuss
hammoudeh
et
al
report
induc
circular
dichroism
icd
effect
cmyc
bind
racem
mixtur
r
form
two
possibl
reason
observ
icd
effect
either
chiral
surround
affect
absorpt
transit
compound
enantiomerspecif
effect
differ
bind
affin
r
form
led
icd
effect
shown
form
bound
much
stronger
cmyc
r
form
therefor
suggest
enantiomerspecif
effect
respons
observ
icd
effect
experi
use
singl
chiral
form
would
help
clarifi
observ
cluster
conform
md
simul
explicit
solvent
model
apo
holo
cmyc
peptid
base
rmsd
backbon
atom
figur
show
repres
conform
top
eight
cluster
apo
holo
peptid
clear
apo
holo
peptid
rather
broad
conform
distribut
typic
disord
protein
upon
bind
ligand
conform
distribut
becam
condens
top
eight
conform
cluster
holo
peptid
highli
popul
compar
apo
peptid
total
occup
compar
similar
apo
cmyc
structur
holo
cmyc
structur
rich
helic
structur
quantit
analysi
indic
helix
polyprolin
ii
content
almost
unaffect
bind
figur
sheet
content
enhanc
see
also
figur
electrostat
interact
charg
residu
hydrogen
bond
domin
intramolecular
stabil
forc
holo
cmyc
figur
bind
free
energi
calcul
use
mmpbsa
method
quantiti
kcalmol
u
nonbond
averag
nonbond
potenti
compos
lennardjon
electrostat
potenti
usual
bind
simultan
two
region
flank
sever
residu
bind
highli
dynam
could
switch
differ
mode
within
trajectori
time
percentag
bind
residu
calcul
shown
figur
three
bind
site
detect
includ
site
residu
site
ii
site
iii
site
near
ntermin
show
stronger
potenc
two
site
result
support
intermolecular
interact
analysi
figur
show
electrostat
lennardjon
interact
site
much
stronger
two
site
fact
latter
case
hydrogen
bond
hardli
form
electrostat
interact
weak
site
similar
experiment
determin
bind
site
cmyc
residu
bind
site
gener
simul
much
weaker
would
make
difficult
observ
experiment
low
residu
interact
specif
observ
simul
consist
recent
simul
residu
peptid
cmyc
suggest
ligand
bind
driven
weak
nonspecif
interact
mass
spectrometri
experi
cmyc
report
harvey
et
al
also
support
conclus
investig
inher
specif
featur
idp
conduct
neg
control
studi
chose
anoth
segment
cmyc
residu
bind
simul
bind
cmyc
shown
figur
specif
idp
molecular
recognit
complic
simul
result
show
specif
cmyc
bind
smallmolecul
ligand
high
cmyc
typic
exampl
idp
sticki
bind
ligand
differ
region
differ
interact
strength
lack
coupl
fold
bind
bind
cmyc
still
ensembl
divers
conform
distinct
conform
capabl
bind
ligand
furthermor
given
cmyc
structur
bind
ligand
occur
dispers
site
figur
name
phenomenon
ligand
cloud
ligand
cloud
remark
differ
type
bind
found
order
protein
domin
bind
structur
form
expect
ligand
cloud
may
gener
featur
idp
bind
smallmolecul
ligand
idp
bind
macromolecul
partner
report
idp
remain
disord
holo
state
exampl
bcateninapc
peptid
bcateninapc
phosphoryl
vifelobeloc
idp
complex
assum
dynam
structur
upon
bind
suggest
idp
may
interact
partner
similar
manner
ligand
cloud
ligand
cloud
concept
support
idea
definit
bind
mode
interact
idp
smallmolecul
inhibitor
suggest
interact
could
describ
protein
cloud
interact
ligand
cloud
ligand
cloud
concept
describ
scenario
interact
idp
smallmolecul
ligand
may
provid
basi
drug
design
target
idp
straightforward
strategi
ration
drug
design
idp
extract
metast
structur
simul
conduct
virtual
screen
identifi
potenti
inhibitor
similar
strategi
appli
success
design
inhibitor
ab
fibril
howev
ligand
cloud
concept
small
molecul
bind
idp
impli
differ
strategi
use
order
protein
develop
better
ration
drug
design
idp
exampl
ligand
bind
idp
occur
dispers
locat
differ
orient
multimod
interact
consid
score
function
instead
singlemod
interact
commonli
use
protein
therefor
scheme
consid
bind
energi
landscap
might
expect
perform
better
design
small
molecul
ligand
idp
hand
contrast
convent
order
protein
either
bind
nonbind
state
small
molecul
idp
sticki
would
either
strong
bind
weak
bind
small
molecul
care
paid
problem
specif
drug
design
target
idp
convent
order
protein
bind
conform
uniqu
could
select
preexist
conform
conform
select
mechan
induc
induc
fit
mechan
particular
ligand
scenario
ligand
cloud
around
protein
cloud
idp
indic
multipl
protein
conform
select
andor
induc
bind
ligand
idp
may
extend
conform
selectioninduc
fit
continuum
new
dimens
conclus
conduct
extens
simul
explor
conform
ensembl
cmyc
complex
smallmolecul
inhibitor
conform
space
found
rather
dispers
contrast
convent
structur
protein
conform
cmyc
mainli
stabil
charg
interact
hydrogen
bond
upon
bind
cmyc
remain
disord
ligand
bound
differ
site
throughout
cmyc
chain
differ
strength
accordingli
ligand
cloud
concept
propos
interact
small
molecul
ligand
idp
like
ligand
cloud
around
protein
cloud
differ
bind
probabl
protein
cloud
ligand
cloud
indic
ligand
could
select
thu
specif
though
specif
bind
high
bind
ligand
nonligand
target
idp
could
clearli
distinguish
hammoudeh
et
al
measur
chemic
shift
sever
noe
signal
cmyc
predict
dihedr
angl
distribut
atom
contact
build
cmyc
peptid
first
built
complet
extend
conform
follow
sequenc
lkrsffalrdqipelennekapkvvilkkatayilsvqa
access
number
built
initi
structur
report
dihedr
angl
use
pymol
apo
holo
structur
cmyc
refin
use
gromac
softwar
packag
forc
field
nmr
data
dihedr
angl
distanc
restraint
simul
initi
structur
minim
vacuum
solvat
minim
equilibr
describ
time
step
set
fs
final
ns
product
simul
perform
final
structur
adopt
refin
structur
conform
cmyc
peptid
sampl
remd
simul
gener
bornsurfac
area
gbsa
implicit
solvent
model
amber
molecular
simul
packag
use
forc
field
total
replica
adopt
temperatur
rang
k
k
adjac
replica
attempt
exchang
temperatur
everi
ps
averag
exchang
rate
produc
start
conform
remd
simul
initi
structur
describ
minim
use
steepest
descent
step
switch
conjug
gradient
anoth
step
minim
conform
heat
defin
temperatur
time
ps
replica
obtain
conform
adopt
start
conform
remd
simul
run
time
step
fs
replica
temperatur
control
coupl
time
constant
ps
bond
involv
hydrogen
atom
constrain
shake
chiral
restraint
backbon
employ
prevent
nonphys
chiral
ionic
strength
set
cutoff
nonbond
interact
gb
pairwis
summat
involv
calcul
born
radii
consid
probabl
interact
entir
snapshot
trajectori
store
everi
ps
conduct
four
group
remd
simul
differ
initi
structur
extend
structur
peptid
b
apo
nmr
refin
structur
c
structur
md
simul
k
start
extend
conform
occupi
repres
conform
gener
previous
remd
simul
extend
structur
simul
time
four
group
remd
ns
ns
ns
ns
respect
total
simul
time
ms
ms
per
replica
trajectori
k
k
k
use
analys
except
trajectori
k
use
chemic
shift
calcul
investig
interact
cmyc
md
simul
complex
structur
carri
explicit
solvent
model
apo
cmyc
also
simul
explicit
solvent
model
comparison
three
group
simul
perform
one
apo
two
holo
two
chiral
form
see
figur
group
contain
seven
trajectori
ms
therefor
total
simul
time
ms
one
seven
initi
structur
nmr
refin
structur
apo
holo
six
initi
structur
adopt
repres
conform
gener
previous
remd
simul
holo
structur
isom
dock
use
autodock
program
md
simul
explicit
solvent
model
perform
gromac
softwar
packag
forc
field
particl
mesh
ewald
period
boundari
condit
water
model
use
forc
field
previous
report
good
perform
simul
idp
holo
simul
small
molecul
ligand
involv
parameter
use
gener
amber
forc
field
gaff
acpyp
softwar
charg
model
use
assign
charg
ligand
initi
structur
immers
explicit
truncat
octahedr
water
box
dimens
box
defin
distanc
farthest
atom
peptid
edg
box
set
system
neutral
ad
ion
extra
nacl
ad
repres
solut
ionic
strength
system
minim
use
steepest
descent
minim
approach
minim
system
equilibr
nvt
ensembl
allheavi
atom
restrain
forc
constant
kcalmol
temperatur
maintain
k
use
vrescal
thermostat
coupl
constant
ps
equilibr
carri
npt
ensembl
without
strain
pressur
maintain
atmospher
use
parrinellorahamn
barostat
coupl
constant
set
ps
equilibr
perform
ps
time
step
fs
product
run
thermostat
barostat
set
npt
run
enabl
fs
time
step
bond
involv
hydrogen
atom
constrain
equilibr
length
use
linc
algorithm
realspac
cutoff
use
electrostat
lennardjon
forc
snapshot
trajectori
store
everi
ps
investig
inher
specif
featur
idp
conduct
neg
control
studi
use
cmyc
truncat
peptid
eqkliseedllrkrreqlkhkleqlrn
bind
extend
structur
peptid
use
initi
structur
ns
implicit
solvent
md
simul
final
structur
gener
appli
allatom
explicit
simul
two
group
simul
perform
two
chiral
isom
group
contain
one
trajectori
ms
paramet
paramet
use
holo
cmyc
simul
describ
simul
analyz
use
gromac
util
either
pymol
inhous
script
dsasa
use
determin
bind
site
upon
small
molecul
bind
residu
peptid
would
clear
decreas
sasa
relat
differ
sasa
bound
unbound
state
backbon
rmsd
cluster
peptid
conform
perform
identifi
distinct
structur
cluster
estim
popul
rel
bind
free
energi
calcul
everi
ps
use
mmpbsa
method
figur
comparison
comput
experiment
chemic
shift
apo
cmyc
comput
valu
use
shiftx
red
circl
camshift
blue
squar
sparta
green
squar
remd
simul
experiment
valu
hammoudeh
et
al
black
triangl
note
experiment
valu
residu
avail
chemic
shift
atom
h
b
h
n
